Company intelligence / Profile preview

Anson Funds

Dallas, Texas, USA

Ownership: Private
Employees: ~4
Development stage: Other

Overview

Anson Funds is a hedge fund manager with $2.5 billion in assets under management, focusing on alternative investment strategies such as event-driven, distressed credit, and merger arbitrage. It is an active investor in public companies including those in life sciences, but does not develop or directly commercialize therapeutics[1][5][7]. It is a significant shareholder and financier for companies like NRx Pharmaceuticals, Universe Pharmaceuticals, and Oncolytics Biotech[6][8][9].

Industry: Investors

Partnerships

Multiple equity/debt financing relationships with healthcare and biotech companies such as NRx Pharmaceuticals[2][4][6], Universe Pharmaceuticals[8], and Oncolytics Biotech[9], but no partnerships as a life science company.

Beyond the preview

Go deeper on Anson Funds.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anson Funds.

Explore the full profile